Table 3.
Coverage per EPI contact by source of information
| Recommended timing of EPI contact | Vaccine | Children aged 10–23 months vaccinated at any time before the HHS, according to: | ||
|---|---|---|---|---|
| Vaccination card n/N (%) |
Caretaker’s report n/N (%) |
Total n/N (%); [95% CI] |
||
| At birth | BCG | 564/720 (78.3) | 137/720 (19.0) | 701/720 (97.4); [95.6–98.4] |
| OPV 0 | 553/720 (74.0) | 137/720 (19.0) | 690/720 (95.8); [93.4–97.4] | |
| At 6 weeks | OPV 1 | 548/720 (76.8) | 127/720 (17.6) | 675/720 (93.8); [90.4–96.0] |
| DTP-HepB-Hib (Pentavalent) 1 | 549/720 (76.3) | 130/720 (18.1) | 679/720 (94.3); [91.1–96.4] | |
| Pneumococcal 1 | 545/720 (75.7) | 128/720 (17.8) | 673/720 (93.5); [90.1–95.7] | |
| Rotavirus 1 | 529/720 (73.5) | 129/720 (17.9) | 658/720 (91.4); [87.7–94.1] | |
| At 10 weeks | OPV 2 | 527/720 (73.2) | 126/720 (17.5) | 653/720 (90.7); [87.0-93.4] |
| DTP-HepB-Hib (Pentavalent) 2 | 531/720 (73.8) | 126/720 (17.5) | 657/720 (91.3); [87.6–93.9] | |
| Pneumococcal 2 | 522/720 (72.5) | 126/720 (17.5) | 648/720 (90.0); [86.3–92.8] | |
| Rotavirus 2 | 498/720 (69.2) | 127/720 (17.6) | 625/720 (86.8); [83.0-89.9] | |
| PMC 1 | 421/720 (58.5) | 153/720 (21.3) | 574/720 (79.7); [74.7–83.9] | |
| At 14 weeks | OPV 3 | 503/720 (69.9) | 122/720 (16.9) | 625/720 (86.8); [82.8–90.0] |
| DTP-HepB-Hib (Pentavalent) 3 | 499/720 (69.3) | 122/720 (16.9) | 621/720 (86.3); [82.4–89.4] | |
| Pneumococcal 3 | 498/720 (69.2) | 120/720 (16.7) | 618/720 (85.8); [81.9–89.0] | |
| IPV | 432/720 (60.0) | 130/720 (18.1) | 562/720 (78.1); [73.6–81.9] | |
| PMC 2 | 452/720 (62.8) | 125/720 (17.4) | 577/720 (80.1); [75.7–83.9] | |
| At 6 months | Vitamin A | 466/720 (64.7) | 119/720 (16.5) | 585/720 (81.3); [76.4–85.3] |
| At 9 months | Yellow fever | 407/720 (56.5) | 96/720 (13.3) | 503/720 (69.9); [64.4–74.8] |
| MCV 1 | 400/720 (55.6) | 101/720 (14.0) | 501/720 (69.6); [64.1–74.5] | |
| PMC 3 | 328/720 (45.6) | 92/720 (12.8) | 420/720 (58.3); [53.0-63.5] | |
| At 12 months | De-worming1 | 259/571 (45.4) | 72/571 (12.6) | 331/571 (58.0); [52.1–63.6] |
| Vitamin A1 | 260/571 (45.5) | 74/571 (13.0) | 334/571 (58.5) [52.7–64.0] | |
| At 15 months | MCV 22 | 128/442 (29.0) | 52/442 (11.8) | 180/442 (40.7) [34.5–47.2] |
BCG = bacille Calmette-Guérin; DTP = diphtheria-tetanus-pertussis; HepB = hepatitis B; Hib = Haemophilus influenzae type b; PMC = perennial malaria chemoprevention; IPV = inactivated polio vaccine; MCV = measles-containing vaccine; OPV = oral polio vaccine
1 Among participants aged 13 months or older, allowing one month of delay
2 Among participants aged 16 months or older, allowing one month of delay